Cargando…
Disease-modifying genes and monogenic disorders: experience in cystic fibrosis
The mechanisms responsible for the determination of phenotypes are still not well understood; however, it has become apparent that modifier genes must play a considerable role in the phenotypic heterogeneity of Mendelian disorders. Significant advances in genetic technologies and molecular medicine...
Autor principal: | Gallati, Sabina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4104546/ https://www.ncbi.nlm.nih.gov/pubmed/25053892 http://dx.doi.org/10.2147/TACG.S18675 |
Ejemplares similares
-
Long-term gas exchange characteristics as markers of deterioration in patients with cystic fibrosis
por: Kraemer, Richard, et al.
Publicado: (2009) -
Progression of pulmonary hyperinflation and trapped gas associated with genetic and environmental factors in children with cystic fibrosis
por: Kraemer, Richard, et al.
Publicado: (2006) -
Gene Therapies for Monogenic Autism Spectrum Disorders
por: Weuring, Wout, et al.
Publicado: (2021) -
Genes and Microbiota Interaction in Monogenic Autoimmune Disorders
por: Costa, Federica, et al.
Publicado: (2023) -
Monogenic Diabetes in a Child with Cystic Fibrosis: A Case Report and Review of the Literature
por: Scully, Kevin J, et al.
Publicado: (2020)